Results 141 to 150 of about 8,927 (183)

Efficacy and safety of secukinumab in conjunction with surgery in moderate to severe hidradenitis suppurativa. [PDF]

JAAD Int
Zheng J, Wu Q, Zhang K, Zhang Q, Lv Q, Wang L, Huang L, Wang Y, Gong X, Li X, Fang F, Bu W.   +11 more
europepmc   +1 more source

Secukinumab

Reactions Weekly, 2016
openaire   +3 more sources

Long-term osteoprotective effects of IL-17A blockade with secukinumab in psoriatic arthritis: data from the PSARTROS-II study. [PDF]

RMD Open
Schuster L, Temiz A, Mutlu MY, Tascilar K, Bayat S, Corte G, Rech J, Hueber A, Liphardt AM, Kleyer A, Simon D, Roemer F, Schett G, Fagni F.   +13 more
europepmc   +1 more source

Patterns of Musculoskeletal Involvement in Hidradenitis Suppurativa: A Pilot Study. [PDF]

Cureus
Suliman Y, Attia E.
europepmc   +1 more source

Biological Therapy for Moderate-to-Severe Psoriasis: A 5-Year Analysis of Patients from Lithuania. [PDF]

Medicina (Kaunas)
Indrisiunaite E, Jonaityte IR, Karmaziene T, Raudonis T.   +3 more
europepmc   +1 more source

Interleukin-17A inhibitors for guttate psoriasis treatment: A retrospective cohort study. [PDF]

JAAD Int
Man XY, Zhao GY, Ye LR.
europepmc   +1 more source

Efficacy of Biologics for Hidradenitis Suppurativa: A Network Meta Analysis and Meta Regression for Baseline Disease Severity. [PDF]

Australas J Dermatol
Pham J, Sholji T, Aghajani M, Maye E, Burrell K, Kok C, Frew JW.   +6 more
europepmc   +1 more source

Secukinumab-Induced Delayed Behçet-Like Reaction in a Patient with Plaque Psoriasis: A Case Report. [PDF]

Clin Cosmet Investig Dermatol
Wei Y, Zhang P, Chuan J, Ye J, Liu T.
europepmc   +1 more source

Familial CARD14-associated papulosquamous eruption with a novel mutation successfully treated with secukinumab. [PDF]

JAAD Case Rep
Ren J, Tan G, Shi Z.
europepmc   +1 more source